Frontiers in Immunology (Jun 2022)
FOXO1 and FOXO3 Cooperatively Regulate Innate Lymphoid Cell Development
- Thuy T. Luu,
- Thuy T. Luu,
- Jonas Nørskov Søndergaard,
- Lucía Peña-Pérez,
- Lucía Peña-Pérez,
- Shabnam Kharazi,
- Shabnam Kharazi,
- Aleksandra Krstic,
- Aleksandra Krstic,
- Stephan Meinke,
- Stephan Meinke,
- Laurent Schmied,
- Laurent Schmied,
- Nicolai Frengen,
- Nicolai Frengen,
- Yaser Heshmati,
- Yaser Heshmati,
- Marcin Kierczak,
- Thibault Bouderlique,
- Thibault Bouderlique,
- Arnika Kathleen Wagner,
- Arnika Kathleen Wagner,
- Charlotte Gustafsson,
- Charlotte Gustafsson,
- Benedict J. Chambers,
- Adnane Achour,
- Claudia Kutter,
- Petter Höglund,
- Petter Höglund,
- Petter Höglund,
- Robert Månsson,
- Robert Månsson,
- Robert Månsson,
- Nadir Kadri
Affiliations
- Thuy T. Luu
- Department of Medicine Huddinge, Huddinge, Karolinska Institute, Stockholm, Sweden
- Thuy T. Luu
- Center for Hematology and Regenerative Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden
- Jonas Nørskov Søndergaard
- Department of Microbiology, Tumor and Cell Biology, Science for Life Laboratory, Karolinska Institute, Stockholm, Sweden
- Lucía Peña-Pérez
- Center for Hematology and Regenerative Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden
- Lucía Peña-Pérez
- Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
- Shabnam Kharazi
- Center for Hematology and Regenerative Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden
- Shabnam Kharazi
- Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
- Aleksandra Krstic
- Center for Hematology and Regenerative Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden
- Aleksandra Krstic
- Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
- Stephan Meinke
- Department of Medicine Huddinge, Huddinge, Karolinska Institute, Stockholm, Sweden
- Stephan Meinke
- Center for Hematology and Regenerative Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden
- Laurent Schmied
- Department of Medicine Huddinge, Huddinge, Karolinska Institute, Stockholm, Sweden
- Laurent Schmied
- Center for Hematology and Regenerative Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden
- Nicolai Frengen
- Center for Hematology and Regenerative Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden
- Nicolai Frengen
- Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
- Yaser Heshmati
- Department of Medicine Huddinge, Huddinge, Karolinska Institute, Stockholm, Sweden
- Yaser Heshmati
- Center for Hematology and Regenerative Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden
- Marcin Kierczak
- Department of Cell and Molecular Biology, National Bioinformatics Infrastructure Sweden, Science for Life Laboratory, Uppsala University, Uppsala, Sweden
- Thibault Bouderlique
- Center for Hematology and Regenerative Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden
- Thibault Bouderlique
- Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
- Arnika Kathleen Wagner
- Department of Medicine Huddinge, Huddinge, Karolinska Institute, Stockholm, Sweden
- Arnika Kathleen Wagner
- Center for Hematology and Regenerative Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden
- Charlotte Gustafsson
- Center for Hematology and Regenerative Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden
- Charlotte Gustafsson
- Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
- Benedict J. Chambers
- Department of Microbiology, Tumor and Cell Biology, Science for Life Laboratory, Karolinska Institute, Stockholm, Sweden
- Adnane Achour
- Science for Life Laboratory, Department of Medicine Solna, Karolinska Institute, and Division of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden
- Claudia Kutter
- Department of Microbiology, Tumor and Cell Biology, Science for Life Laboratory, Karolinska Institute, Stockholm, Sweden
- Petter Höglund
- Department of Medicine Huddinge, Huddinge, Karolinska Institute, Stockholm, Sweden
- Petter Höglund
- Center for Hematology and Regenerative Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden
- Petter Höglund
- Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, Stockholm, Sweden
- Robert Månsson
- Center for Hematology and Regenerative Medicine, Huddinge, Karolinska Institute, Stockholm, Sweden
- Robert Månsson
- Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden
- Robert Månsson
- Department of Hematology, Karolinska University Hospital, Stockholm, Sweden
- Nadir Kadri
- Science for Life Laboratory, Department of Medicine Solna, Karolinska Institute, and Division of Infectious Diseases, Karolinska University Hospital, Stockholm, Sweden
- DOI
- https://doi.org/10.3389/fimmu.2022.854312
- Journal volume & issue
-
Vol. 13
Abstract
Natural killer (NK) cells play roles in viral clearance and early surveillance against malignant transformation, yet our knowledge of the underlying mechanisms controlling their development and functions remain incomplete. To reveal cell fate-determining pathways in NK cell progenitors (NKP), we utilized an unbiased approach and generated comprehensive gene expression profiles of NK cell progenitors. We found that the NK cell program was gradually established in the CLP to preNKP and preNKP to rNKP transitions. In line with FOXO1 and FOXO3 being co-expressed through the NK developmental trajectory, the loss of both perturbed the establishment of the NK cell program and caused stalling in both NK cell development and maturation. In addition, we found that the combined loss of FOXO1 and FOXO3 caused specific changes to the composition of the non-cytotoxic innate lymphoid cell (ILC) subsets in bone marrow, spleen, and thymus. By combining transcriptome and chromatin profiling, we revealed that FOXO TFs ensure proper NK cell development at various lineage-commitment stages through orchestrating distinct molecular mechanisms. Combined FOXO1 and FOXO3 deficiency in common and innate lymphoid cell progenitors resulted in reduced expression of genes associated with NK cell development including ETS-1 and their downstream target genes. Lastly, we found that FOXO1 and FOXO3 controlled the survival of committed NK cells via gene regulation of IL-15Rβ (CD122) on rNKPs and bone marrow NK cells. Overall, we revealed that FOXO1 and FOXO3 function in a coordinated manner to regulate essential developmental genes at multiple stages during murine NK cell and ILC lineage commitment.
Keywords